Ventolin: Clinical Trials

11 trials of Ventolin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 3 withdrawn, 2 terminated, 1 not yet recruiting. 11 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 411Completed 5, Withdrawn 3, Terminated 2, Not yet recruiting 1

Follow Ventolin: new trials by email Literature Review of Ventolin trials Research Report on Ventolin

Trials (filtered) newest first · largest first

All 11 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy of Nebulized Long-Acting Bronchodilators (Formoterol and Revefenacin) vs. Short-Acting Bronchodilators (Albuterol and Ipratropium) in Patients Presenting to the Emergency Department With Acute Exacerbation of COPD (ECOPD)
Revefenacin, formoterol fumarate, Placebo (Sterile Normal Saline) - COPD Exacerbation
Phase 4Not yet recruitingUniversity of Tennessee Graduate School of Medicine2802026-11-122026-10-19
Mechanisms for Dyspnea on Exertion in Children With Obesity and Asthma: Distinct Physiological Phenotypes
Control, Albuterol - Asthma in Children, Dyspnea; Asthmatic
Phase 4WithdrawnOhio State University2023-07-012023-11-07
Bronchodilators for Wheeze in Young Children Presenting to Primary Care: a Randomised, Placebo-controlled, Multicentre, Parallel Group Trial
Salbutamol, Placebo - Wheezing
Phase 4WithdrawnUMC Utrecht2021-09-012021-07-23
Reducing Exercise-induced Bronchoconstriction in Children With Asthma and Obesity
Albuterol Sulfate, Interval Warm-up exercise - Asthma in Children, Obesity, Childhood
Phase 4TerminatedUniversity of Nevada, Las Vegas342018-09-182021-07-22
Supervised Asthma Medication in Schools (SAMS)
Supervised asthma therapy in schools - Childhood Asthma
Phase 4CompletedUniversity of Arizona4422014-08-012022-03-23
Preterm Infant Inhaled Albuterol Dosing
Varied albuterol dose response - Bronchopulmonary Dysplasia, Very Low Birth Weight
Phase 4CompletedOregon Health and Science University142013-10-242019-05-23
Salbutamol, Pharmacogenetics and Breathing Mechanics
Salbutamol, Placebo - Bronchoconstriction, Inhaled Salbutamol
Phase 4CompletedUniversity of British Columbia942013-05-012016-11-02
Peak Bronchoprotection Conferred by Levosalbutamol and Racemic Salbutamol
levosalbutamol, racemic salbutamol, placebo - Asthma
Phase 4WithdrawnUniversity of Dundee2009-01-012012-06-12
Trough Bronchoprotection Conferred by Levosalbutamol and Racemic Salbutamol
levosalbutamol, racemic salbutamol, placebo - Asthma
Phase 4CompletedUniversity of Dundee302009-01-012019-04-12
Bronchodilators and Respiratory Mechanics in Chronic Obstructive Pulmonary Disease (COPD) Patients
Salbutamol + Tiotropium, Placebo + Tiotropium - Chronic Obstructive Pulmonary Disease
Phase 4TerminatedIRCCS Azienda Ospedaliero-Universitaria di Bologna202008-09-012012-07-17
Study to Assess the Effect of Salbutamol and Ipratropium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients
Salbutamol, ipratropium bromide - COPD
Phase 4CompletedUniversity Hospital, Antwerp62008-06-012009-06-02

Conditions studied

Asthma (3)  ·  Pediatric Obesity (2)  ·  Pulmonary Disease, Chronic Obstructive (2)  ·  Asthma, Exercise-Induced (1)  ·  Bronchopulmonary Dysplasia (1)  ·  Dyspnea (1)  ·  Motor Activity (1)  ·  Respiratory Sounds (1)

Sponsors

University of Dundee (2)  ·  IRCCS Azienda Ospedaliero-Universitaria di Bologna (1)  ·  Ohio State University (1)  ·  Oregon Health and Science University (1)  ·  UMC Utrecht (1)  ·  University Hospital, Antwerp (1)  ·  University of Arizona (1)  ·  University of British Columbia (1)  ·  University of Nevada, Las Vegas (1)  ·  University of Tennessee Graduate School of Medicine (1)

Countries

United States (5)  ·  United Kingdom (2)  ·  Belgium (1)  ·  Canada (1)  ·  Italy (1)

Top investigators

Brian J Lipworth, MBchB (2)  ·  Karine L Clearie, MBBS, MRCP (2)  ·  Amanda Kim, MD (1)  ·  Ann van den Bruel, Professor (1)  ·  Cynthia McEvoy, MD, MCR (1)  ·  Dharini M Bhammar, MBBS, PhD (1)  ·  Dharini M Bhammar, Ph.D. (1)  ·  Lynn B Gerald, Ph.D., MSPH (1)  ·  Michael S Koehle, MD, PhD (1)  ·  Wilfried A De Backer, MD PhD (1)

Results publications

PMID 23829494, PMID 30118728

NIH funding

R18HL110858 (1)